300401 Stock Overview
Zhejiang Garden Biopharmaceutical Co.,Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Zhejiang Garden Biopharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥15.44 |
| 52 Week High | CN¥18.46 |
| 52 Week Low | CN¥7.58 |
| Beta | 0.085 |
| 1 Month Change | 0.72% |
| 3 Month Change | 26.14% |
| 1 Year Change | 40.62% |
| 3 Year Change | 12.21% |
| 5 Year Change | 27.71% |
| Change since IPO | 665.11% |
Recent News & Updates
Zhejiang Garden BiopharmaceuticalLtd's (SZSE:300401) Profits May Not Reveal Underlying Issues
Oct 24
Zhejiang Garden BiopharmaceuticalLtd (SZSE:300401) Has A Somewhat Strained Balance Sheet
Sep 29Recent updates
Zhejiang Garden BiopharmaceuticalLtd's (SZSE:300401) Profits May Not Reveal Underlying Issues
Oct 24Zhejiang Garden BiopharmaceuticalLtd (SZSE:300401) Has A Somewhat Strained Balance Sheet
Sep 29Zhejiang Garden Biopharmaceutical Co.,Ltd.'s (SZSE:300401) Stock Retreats 26% But Earnings Haven't Escaped The Attention Of Investors
Sep 08Why Investors Shouldn't Be Surprised By Zhejiang Garden Biopharmaceutical Co.,Ltd.'s (SZSE:300401) 27% Share Price Surge
Jun 30Is Zhejiang Garden BiopharmaceuticalLtd (SZSE:300401) A Risky Investment?
May 31Subdued Growth No Barrier To Zhejiang Garden Biopharmaceutical Co.,Ltd. (SZSE:300401) With Shares Advancing 27%
May 06Why Zhejiang Garden BiopharmaceuticalLtd's (SZSE:300401) Shaky Earnings Are Just The Beginning Of Its Problems
Apr 22Shareholder Returns
| 300401 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 1.3% | -0.9% | -0.06% |
| 1Y | 40.6% | -2.7% | 11.1% |
Return vs Industry: 300401 exceeded the CN Pharmaceuticals industry which returned -2.7% over the past year.
Return vs Market: 300401 exceeded the CN Market which returned 11.1% over the past year.
Price Volatility
| 300401 volatility | |
|---|---|
| 300401 Average Weekly Movement | 8.6% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 300401 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300401's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 943 | Huanzheng Ma | www.hybiotech.com |
Zhejiang Garden Biopharmaceutical Co.,Ltd. manufactures and supplies lanolin cholesterol, vitamin D3, 25-hydroxyvitamin D3, and refined lanolin products in China. It offers cholesterol; feed grade cholesterol; food additives compound nutrient fortifier SDS, CO, and MO; cholecalciferol; feed additive - vitamin D3 particles and oil; VD3 resin oil; 25 hydroxyvitamin D3 progen and powder; 25 hydroxyvitamin D3; anhydrous lanolin; wood oil; wool wax; low chroma pure fat; lanolin alcohol; isopropyl lanolate; lanolinic acid; high acid fat; wood acid biofuel/wood alcohol biofuel; and rodenticide made from Vitamin D3.
Zhejiang Garden Biopharmaceutical Co.,Ltd. Fundamentals Summary
| 300401 fundamental statistics | |
|---|---|
| Market cap | CN¥8.59b |
| Earnings (TTM) | CN¥284.89m |
| Revenue (TTM) | CN¥1.13b |
29.5x
P/E Ratio7.4x
P/S RatioIs 300401 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300401 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.13b |
| Cost of Revenue | CN¥473.20m |
| Gross Profit | CN¥661.26m |
| Other Expenses | CN¥376.38m |
| Earnings | CN¥284.89m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.52 |
| Gross Margin | 58.29% |
| Net Profit Margin | 25.11% |
| Debt/Equity Ratio | 55.6% |
How did 300401 perform over the long term?
See historical performance and comparison